Ignite Creation Date:
2025-12-25 @ 4:55 AM
Ignite Modification Date:
2026-01-15 @ 1:41 PM
Study NCT ID:
NCT05168618
Status:
RECRUITING
Last Update Posted:
2025-05-07
First Post:
2021-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Sponsor:
Organization: